These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5283016)

  • 1. Cell hybridization study of resistance to alkylating agents.
    Phillips BJ; Ambrose EJ
    Nat New Biol; 1971 Jun; 231(22):146-7. PubMed ID: 5283016
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.
    Mandel HG; Connors TA; Melzack DH; Merai K
    Cancer Res; 1974 Feb; 34(2):275-80. PubMed ID: 4855748
    [No Abstract]   [Full Text] [Related]  

  • 3. Alkylating analogues of the tumour inhibitor 5-aziridino-2,4-dinitrobenzamide.
    Tisdale MJ
    Chem Biol Interact; 1971 Apr; 3(2):95-107. PubMed ID: 5156644
    [No Abstract]   [Full Text] [Related]  

  • 4. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase.
    Lalka D; Bardos TJ
    Biochem Pharmacol; 1975 Feb; 24(4):455-6. PubMed ID: 1167458
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
    Tisdale MJ; Habberfield AD
    Biochem Pharmacol; 1980 Oct; 29(20):2845-53. PubMed ID: 7002161
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of alkylating agents on adenosine 3',5'-monophosphate metabolism in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(15):1793-7. PubMed ID: 182174
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour.
    Connors TA; Melzack DH
    Int J Cancer; 1971 Jan; 7(1):86-92. PubMed ID: 5546147
    [No Abstract]   [Full Text] [Related]  

  • 11. Haptenic activity of L-phenylalanine mustard.
    Arai K; Wallace HW; Blakemore WS
    Cancer Res; 1973 Aug; 33(8):1905-13. PubMed ID: 4198384
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the protection by imidazoles against the cytotoxicity of the antitumour alkylating agents melphalan and CB 1954.
    Hickman JA; Melzack DH
    Biochem Pharmacol; 1976 Nov; 25(22):2489-91. PubMed ID: 985571
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticancer activity of alkylating agents derived from various diamines and diols on Ehrlich Ascites carcinoma.
    Skinner WA; Scholler J
    Cancer Chemother Rep; 1967 Aug; 51(4):205-11. PubMed ID: 5623729
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the reversal of the selective antitumour effect of the aziridinyl derivative CB 1954 by 4-amino-5-imidazolecarboxamide.
    Connors TA; Mandel HG; Melzack DH
    Int J Cancer; 1972 Jan; 9(1):126-32. PubMed ID: 5015661
    [No Abstract]   [Full Text] [Related]  

  • 16. Preferential cytotoxicity of some novel alkylating agents under hypoxic conditions.
    Frearson M; Lee JB; Zaidi KF
    Pharmacol Res Commun; 1979 Mar; 11(3):237-43. PubMed ID: 461490
    [No Abstract]   [Full Text] [Related]  

  • 17. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
    Cobb LM; Connors TA; Elson LA; Khan AH; Mitchley BC; Ross WC; Whisson ME
    Biochem Pharmacol; 1969 Jun; 18(6):1519-27. PubMed ID: 4307990
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of alkylating agents derived from diamines on fertility of the male mouse.
    Skinner WA; Tong HC
    Experientia; 1968 Sep; 24(9):924-5. PubMed ID: 5709039
    [No Abstract]   [Full Text] [Related]  

  • 19. Alkylating agents related to 2,2'-biaziridine. II. N,N'-dicarbethoxy-2,2'-biaziridine.
    Feit PW; Nielsen OT
    J Med Chem; 1967 Sep; 10(5):927-32. PubMed ID: 6048504
    [No Abstract]   [Full Text] [Related]  

  • 20. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells.
    Roberts JJ; Friedlos F; Knox RJ
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1073-8. PubMed ID: 3778483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.